ID   PAK3_HUMAN              Reviewed;         559 AA.
AC   O75914; A8K389; B1GX77; B1GX78; B1GX79; Q5JWX1; Q5JWX2; Q7Z2D6; Q7Z2E4;
AC   Q7Z3Z8; Q8WWK5; Q8WX23; Q9P0J8;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   12-OCT-2022, entry version 213.
DE   RecName: Full=Serine/threonine-protein kinase PAK 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Beta-PAK;
DE   AltName: Full=Oligophrenin-3;
DE   AltName: Full=p21-activated kinase 3;
DE            Short=PAK-3;
GN   Name=PAK3; Synonyms=OPHN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INVOLVEMENT IN XLID30.
RX   PubMed=9731525; DOI=10.1038/1675;
RA   Allen K.M., Gleeson J.G., Bagrodia S., Partington M.W., Macmillan J.C.,
RA   Cerione R.A., Mulley J.C., Walsh C.A.;
RT   "PAK3 mutation in nonsyndromic X-linked mental retardation.";
RL   Nat. Genet. 20:25-30(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal gland;
RA   Jiang C., Gu J., Fu S., Ren S., Gu Y., Huang Q., Dong H., Yu Y., Fu G.,
RA   Wang Y., Chen Z., Han Z.;
RT   "A novel gene expressed in the human adrenal gland.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12777533; DOI=10.1093/molbev/msg134;
RA   Kitano T., Schwarz C., Nickel B., Paeaebo S.;
RT   "Gene diversity patterns at 10 X-chromosomal loci in humans and
RT   chimpanzees.";
RL   Mol. Biol. Evol. 20:1281-1289(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=18507705; DOI=10.1111/j.1471-4159.2008.05474.x;
RA   Kreis P., Rousseau V., Thevenot E., Combeau G., Barnier J.V.;
RT   "The four mammalian splice variants encoded by the p21-activated kinase 3
RT   gene have different biological properties.";
RL   J. Neurochem. 106:1184-1197(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   INTERACTION WITH GIT1 AND GIT2.
RX   PubMed=10896954; DOI=10.1074/jbc.275.29.22373;
RA   Premont R.T., Claing A., Vitale N., Perry S.J., Lefkowitz R.J.;
RT   "The GIT family of ADP-ribosylation factor GTPase-activating proteins.
RT   Functional diversity of GIT2 through alternative splicing.";
RL   J. Biol. Chem. 275:22373-22380(2000).
RN   [9]
RP   AUTOPHOSPHORYLATION.
RX   PubMed=11278486; DOI=10.1074/jbc.m009316200;
RA   Chong C., Tan L., Lim L., Manser E.;
RT   "The mechanism of PAK activation. Autophosphorylation events in both
RT   regulatory and kinase domains control activity.";
RL   J. Biol. Chem. 276:17347-17353(2001).
RN   [10]
RP   INTERACTION WITH ARHGEF6 AND ARHGEF7.
RX   PubMed=11741931; DOI=10.1074/jbc.m107704200;
RA   Feng Q., Albeck J.G., Cerione R.A., Yang W.;
RT   "Regulation of the Cool/Pix proteins: key binding partners of the Cdc42/Rac
RT   targets, the p21-activated kinases.";
RL   J. Biol. Chem. 277:5644-5650(2002).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=12890786; DOI=10.1523/jneurosci.23-17-06914.2003;
RA   McPhie D.L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K.J.,
RA   Manly S.P., Kozlowski M.R., Neve K.A., Neve R.L.;
RT   "DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease
RT   mutants of the amyloid precursor protein are mediated by the p21 activated
RT   kinase PAK3.";
RL   J. Neurosci. 23:6914-6927(2003).
RN   [12]
RP   NEDDYLATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-translational
RT   modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [13]
RP   FUNCTION IN PHOSPHORYLATION OF MAPK4 AND MAPK6.
RX   PubMed=21177870; DOI=10.1074/jbc.m110.181529;
RA   Deleris P., Trost M., Topisirovic I., Tanguay P.L., Borden K.L.,
RA   Thibault P., Meloche S.;
RT   "Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated
RT   kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5
RT   signaling pathway.";
RL   J. Biol. Chem. 286:6470-6478(2011).
RN   [14]
RP   REVIEW ON FUNCTION.
RX   PubMed=19036346; DOI=10.1016/j.cellsig.2008.11.001;
RA   Kreis P., Barnier J.V.;
RT   "PAK signalling in neuronal physiology.";
RL   Cell. Signal. 21:384-393(2009).
RN   [15]
RP   VARIANT XLID30 CYS-67.
RX   PubMed=10946356;
RX   DOI=10.1002/1096-8628(20000814)93:4<294::aid-ajmg8>3.0.co;2-f;
RA   Bienvenu T., des Portes V., McDonell N., Carrie A., Zemni R., Couvert P.,
RA   Ropers H.-H., Moraine C., van Bokhoven H., Fryns J.-P., Allen K.,
RA   Walsh C.A., Boue J., Kahn A., Chelly J., Beldjord C.;
RT   "Missense mutation in PAK3, R67C, causes X-linked nonspecific mental
RT   retardation.";
RL   Am. J. Med. Genet. 93:294-298(2000).
RN   [16]
RP   VARIANT XLID30 GLU-380.
RX   PubMed=12884430; DOI=10.1002/ajmg.a.20131;
RA   Gedeon A.K., Nelson J., Gecz J., Mulley J.C.;
RT   "X-linked mild non-syndromic mental retardation with neuropsychiatric
RT   problems and the missense mutation A365E in PAK3.";
RL   Am. J. Med. Genet. A 120:509-517(2003).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-440.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase that plays a role in a
CC       variety of different signaling pathways including cytoskeleton
CC       regulation, cell migration, or cell cycle regulation. Plays a role in
CC       dendrite spine morphogenesis as well as synapse formation and
CC       plasticity. Acts as downstream effector of the small GTPases CDC42 and
CC       RAC1. Activation by the binding of active CDC42 and RAC1 results in a
CC       conformational change and a subsequent autophosphorylation on several
CC       serine and/or threonine residues. Phosphorylates MAPK4 and MAPK6 and
CC       activates the downstream target MAPKAPK5, a regulator of F-actin
CC       polymerization and cell migration. Additionally, phosphorylates
CC       TNNI3/troponin I to modulate calcium sensitivity and relaxation
CC       kinetics of thin myofilaments. May also be involved in early neuronal
CC       development. In hippocampal neurons, necessary for the formation of
CC       dendritic spines and excitatory synapses; this function is dependent on
CC       kinase activity and may be exerted by the regulation of actomyosin
CC       contractility through the phosphorylation of myosin II regulatory light
CC       chain (MLC) (By similarity). {ECO:0000250|UniProtKB:Q61036,
CC       ECO:0000269|PubMed:21177870}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by binding small G proteins. Binding of
CC       GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers
CC       from the autoinhibited dimer, enables phosphorylation of Thr-436 and
CC       allows the kinase domain to adopt an active structure (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound CDC42/p21
CC       and RAC1. Shows highly specific binding to the SH3 domains of
CC       phospholipase C-gamma and of adapter protein NCK. Interacts with the C-
CC       terminal of APP (By similarity). Interacts with ARHGEF6 and ARHGEF7.
CC       Interacts with GIT1 and GIT2 (PubMed:10896954). {ECO:0000250,
CC       ECO:0000269|PubMed:10896954, ECO:0000269|PubMed:11741931}.
CC   -!- INTERACTION:
CC       O75914; P60953-2: CDC42; NbExp=2; IntAct=EBI-3389553, EBI-287394;
CC       O75914-2; Q9H4E5: RHOJ; NbExp=3; IntAct=EBI-17483970, EBI-6285694;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PAK3b;
CC         IsoId=O75914-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75914-2; Sequence=VSP_010242;
CC       Name=3; Synonyms=PAK3cb;
CC         IsoId=O75914-3; Sequence=VSP_041839;
CC       Name=4; Synonyms=PAK3c;
CC         IsoId=O75914-4; Sequence=VSP_041840;
CC   -!- TISSUE SPECIFICITY: Restricted to the nervous system. Highly expressed
CC       in postmitotic neurons of the developing and postnatal cerebral cortex
CC       and hippocampus. {ECO:0000269|PubMed:12890786}.
CC   -!- PTM: Autophosphorylated when activated by CDC42/p21.
CC   -!- PTM: Neddylated. {ECO:0000269|PubMed:20596523}.
CC   -!- DISEASE: Intellectual developmental disorder, X-linked 30 (XLID30)
CC       [MIM:300558]: A disorder characterized by significantly below average
CC       general intellectual functioning associated with impairments in
CC       adaptive behavior and manifested during the developmental period.
CC       Intellectual deficiency is the only primary symptom of non-syndromic X-
CC       linked forms, while syndromic intellectual disability presents with
CC       associated physical, neurological and/or psychiatric manifestations.
CC       {ECO:0000269|PubMed:10946356, ECO:0000269|PubMed:12884430,
CC       ECO:0000269|PubMed:9731525}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF068864; AAC36097.1; -; mRNA.
DR   EMBL; AF155651; AAF67008.1; -; mRNA.
DR   EMBL; AB102659; BAC81128.1; -; mRNA.
DR   EMBL; AB102251; BAC80750.1; -; Genomic_DNA.
DR   EMBL; AB102252; BAC80751.1; -; Genomic_DNA.
DR   EMBL; AB102253; BAC80752.1; -; Genomic_DNA.
DR   EMBL; AB102254; BAC80753.1; -; Genomic_DNA.
DR   EMBL; AB102255; BAC80754.1; -; Genomic_DNA.
DR   EMBL; AB102256; BAC80755.1; -; Genomic_DNA.
DR   EMBL; AB102257; BAC80756.1; -; Genomic_DNA.
DR   EMBL; AB102258; BAC80757.1; -; Genomic_DNA.
DR   EMBL; AB102259; BAC80758.1; -; Genomic_DNA.
DR   EMBL; AB102260; BAC80759.1; -; Genomic_DNA.
DR   EMBL; AB102261; BAC80760.1; -; Genomic_DNA.
DR   EMBL; AB102262; BAC80761.1; -; Genomic_DNA.
DR   EMBL; AB102263; BAC80762.1; -; Genomic_DNA.
DR   EMBL; AB102264; BAC80763.1; -; Genomic_DNA.
DR   EMBL; AB102265; BAC80764.1; -; Genomic_DNA.
DR   EMBL; AB102266; BAC80765.1; -; Genomic_DNA.
DR   EMBL; AB102267; BAC80766.1; -; Genomic_DNA.
DR   EMBL; AB102268; BAC80767.1; -; Genomic_DNA.
DR   EMBL; AB102269; BAC80768.1; -; Genomic_DNA.
DR   EMBL; AB102270; BAC80769.1; -; Genomic_DNA.
DR   EMBL; AB102281; BAC80780.1; -; Genomic_DNA.
DR   EMBL; AB102282; BAC80781.1; -; Genomic_DNA.
DR   EMBL; AB102283; BAC80782.1; -; Genomic_DNA.
DR   EMBL; AB102284; BAC80783.1; -; Genomic_DNA.
DR   EMBL; AB102285; BAC80784.1; -; Genomic_DNA.
DR   EMBL; AB102286; BAC80785.1; -; Genomic_DNA.
DR   EMBL; AB102287; BAC80786.1; -; Genomic_DNA.
DR   EMBL; AB102288; BAC80787.1; -; Genomic_DNA.
DR   EMBL; AB102289; BAC80788.1; -; Genomic_DNA.
DR   EMBL; AB102290; BAC80789.1; -; Genomic_DNA.
DR   EMBL; AB102291; BAC80790.1; -; Genomic_DNA.
DR   EMBL; AB102292; BAC80791.1; -; Genomic_DNA.
DR   EMBL; AB102293; BAC80792.1; -; Genomic_DNA.
DR   EMBL; AB102294; BAC80793.1; -; Genomic_DNA.
DR   EMBL; AB102295; BAC80794.1; -; Genomic_DNA.
DR   EMBL; AB102296; BAC80795.1; -; Genomic_DNA.
DR   EMBL; AB102297; BAC80796.1; -; Genomic_DNA.
DR   EMBL; AB102298; BAC80797.1; -; Genomic_DNA.
DR   EMBL; AB102299; BAC80798.1; -; Genomic_DNA.
DR   EMBL; AB102300; BAC80799.1; -; Genomic_DNA.
DR   EMBL; AM943850; CAQ16016.1; -; mRNA.
DR   EMBL; AM943851; CAQ16017.1; -; mRNA.
DR   EMBL; AM943852; CAQ16018.1; -; mRNA.
DR   EMBL; AK290504; BAF83193.1; -; mRNA.
DR   EMBL; AL356578; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357774; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL031117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117326; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471120; EAX02654.1; -; Genomic_DNA.
DR   CCDS; CCDS14554.1; -. [O75914-2]
DR   CCDS; CCDS48151.1; -. [O75914-3]
DR   CCDS; CCDS48152.1; -. [O75914-4]
DR   CCDS; CCDS48153.1; -. [O75914-1]
DR   RefSeq; NP_001121638.1; NM_001128166.2. [O75914-2]
DR   RefSeq; NP_001121639.1; NM_001128167.2. [O75914-2]
DR   RefSeq; NP_001121640.1; NM_001128168.2. [O75914-3]
DR   RefSeq; NP_001121644.1; NM_001128172.2. [O75914-4]
DR   RefSeq; NP_001121645.1; NM_001128173.2. [O75914-1]
DR   RefSeq; NP_001311254.1; NM_001324325.1. [O75914-2]
DR   RefSeq; NP_001311255.1; NM_001324326.1. [O75914-2]
DR   RefSeq; NP_001311256.1; NM_001324327.1. [O75914-1]
DR   RefSeq; NP_001311257.1; NM_001324328.1. [O75914-1]
DR   RefSeq; NP_001311258.1; NM_001324329.1. [O75914-1]
DR   RefSeq; NP_001311259.1; NM_001324330.1. [O75914-2]
DR   RefSeq; NP_001311260.1; NM_001324331.1. [O75914-2]
DR   RefSeq; NP_001311261.1; NM_001324332.1. [O75914-2]
DR   RefSeq; NP_001311262.1; NM_001324333.1. [O75914-1]
DR   RefSeq; NP_001311263.1; NM_001324334.1. [O75914-2]
DR   RefSeq; NP_002569.1; NM_002578.4. [O75914-2]
DR   RefSeq; XP_016885046.1; XM_017029557.1. [O75914-1]
DR   RefSeq; XP_016885050.1; XM_017029561.1. [O75914-2]
DR   RefSeq; XP_016885052.1; XM_017029563.1. [O75914-3]
DR   PDB; 6FD3; X-ray; 1.52 A; A=261-559.
DR   PDBsum; 6FD3; -.
DR   AlphaFoldDB; O75914; -.
DR   SMR; O75914; -.
DR   BioGRID; 111099; 29.
DR   IntAct; O75914; 6.
DR   MINT; O75914; -.
DR   STRING; 9606.ENSP00000353864; -.
DR   BindingDB; O75914; -.
DR   ChEMBL; CHEMBL2999; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; O75914; -.
DR   GuidetoPHARMACOLOGY; 2135; -.
DR   GlyGen; O75914; 2 sites.
DR   iPTMnet; O75914; -.
DR   MetOSite; O75914; -.
DR   PhosphoSitePlus; O75914; -.
DR   BioMuta; PAK3; -.
DR   EPD; O75914; -.
DR   jPOST; O75914; -.
DR   MassIVE; O75914; -.
DR   PaxDb; O75914; -.
DR   PeptideAtlas; O75914; -.
DR   PRIDE; O75914; -.
DR   ProteomicsDB; 50266; -. [O75914-1]
DR   ProteomicsDB; 50267; -. [O75914-2]
DR   ProteomicsDB; 50268; -. [O75914-3]
DR   ProteomicsDB; 50269; -. [O75914-4]
DR   Antibodypedia; 29512; 532 antibodies from 36 providers.
DR   DNASU; 5063; -.
DR   Ensembl; ENST00000262836.6; ENSP00000262836.4; ENSG00000077264.16. [O75914-1]
DR   Ensembl; ENST00000360648.8; ENSP00000353864.4; ENSG00000077264.16. [O75914-3]
DR   Ensembl; ENST00000372007.10; ENSP00000361077.4; ENSG00000077264.16. [O75914-2]
DR   Ensembl; ENST00000372010.5; ENSP00000361080.1; ENSG00000077264.16. [O75914-1]
DR   Ensembl; ENST00000417227.5; ENSP00000389172.1; ENSG00000077264.16. [O75914-4]
DR   Ensembl; ENST00000425146.5; ENSP00000401982.1; ENSG00000077264.16. [O75914-2]
DR   Ensembl; ENST00000446737.5; ENSP00000410853.1; ENSG00000077264.16. [O75914-2]
DR   Ensembl; ENST00000518291.5; ENSP00000428921.1; ENSG00000077264.16. [O75914-3]
DR   Ensembl; ENST00000519681.5; ENSP00000429113.1; ENSG00000077264.16. [O75914-4]
DR   GeneID; 5063; -.
DR   KEGG; hsa:5063; -.
DR   MANE-Select; ENST00000372007.10; ENSP00000361077.4; NM_002578.5; NP_002569.1. [O75914-2]
DR   UCSC; uc004eoz.3; human. [O75914-1]
DR   CTD; 5063; -.
DR   DisGeNET; 5063; -.
DR   GeneCards; PAK3; -.
DR   HGNC; HGNC:8592; PAK3.
DR   HPA; ENSG00000077264; Group enriched (brain, pancreas, pituitary gland).
DR   MalaCards; PAK3; -.
DR   MIM; 300142; gene.
DR   MIM; 300558; phenotype.
DR   neXtProt; NX_O75914; -.
DR   OpenTargets; ENSG00000077264; -.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA32919; -.
DR   VEuPathDB; HostDB:ENSG00000077264; -.
DR   eggNOG; KOG0578; Eukaryota.
DR   GeneTree; ENSGT00950000182988; -.
DR   HOGENOM; CLU_000288_26_6_1; -.
DR   InParanoid; O75914; -.
DR   OMA; LPEXKSA; -.
DR   OrthoDB; 750735at2759; -.
DR   PhylomeDB; O75914; -.
DR   TreeFam; TF105351; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   PathwayCommons; O75914; -.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-3928664; Ephrin signaling.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-428540; Activation of RAC1.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013409; RHOJ GTPase cycle.
DR   Reactome; R-HSA-9013420; RHOU GTPase cycle.
DR   SignaLink; O75914; -.
DR   SIGNOR; O75914; -.
DR   BioGRID-ORCS; 5063; 12 hits in 731 CRISPR screens.
DR   ChiTaRS; PAK3; human.
DR   GeneWiki; PAK3; -.
DR   GenomeRNAi; 5063; -.
DR   Pharos; O75914; Tchem.
DR   PRO; PR:O75914; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; O75914; protein.
DR   Bgee; ENSG00000077264; Expressed in middle temporal gyrus and 155 other tissues.
DR   ExpressionAtlas; O75914; baseline and differential.
DR   Genevisible; O75914; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0031267; F:small GTPase binding; IEA:Ensembl.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0016358; P:dendrite development; ISS:UniProtKB.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IEA:Ensembl.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; IEA:Ensembl.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IDA:UniProtKB.
DR   GO; GO:0050770; P:regulation of axonogenesis; IBA:GO_Central.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050808; P:synapse organization; TAS:UniProtKB.
DR   CDD; cd01093; CRIB_PAK_like; 1.
DR   CDD; cd06656; STKc_PAK3; 1.
DR   Gene3D; 3.90.810.10; -; 1.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR036936; CRIB_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR033923; PAK_BD.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR035063; STK_PAK3.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Cytoplasm; Developmental protein; Disease variant; Intellectual disability;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; SH3-binding;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..559
FT                   /note="Serine/threonine-protein kinase PAK 3"
FT                   /id="PRO_0000086469"
FT   DOMAIN          70..83
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   DOMAIN          283..534
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..72
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          65..150
FT                   /note="Autoregulatory region"
FT                   /evidence="ECO:0000250"
FT   REGION          65..123
FT                   /note="GTPase-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          84..282
FT                   /note="Linker"
FT   REGION          164..212
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          228..262
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        18..32
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        56..72
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        184..201
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        402
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         289..297
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         312
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62829"
FT   MOD_RES         50
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62829"
FT   MOD_RES         154
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62829"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61036"
FT   MOD_RES         436
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q62829"
FT   VAR_SEQ         92..107
FT                   /note="TPDLYGSQMCPGKLPE -> TNSPFQTSRPVTVASSQSEGKM (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:18507705"
FT                   /id="VSP_041840"
FT   VAR_SEQ         92
FT                   /note="T -> TNSPFQTSRPVTVASSQSEGKM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:18507705"
FT                   /id="VSP_041839"
FT   VAR_SEQ         93..107
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:9731525, ECO:0000303|Ref.2"
FT                   /id="VSP_010242"
FT   VARIANT         67
FT                   /note="R -> C (in XLID30; dbSNP:rs121434612)"
FT                   /evidence="ECO:0000269|PubMed:10946356"
FT                   /id="VAR_023825"
FT   VARIANT         380
FT                   /note="A -> E (in XLID30; dbSNP:rs121434613)"
FT                   /evidence="ECO:0000269|PubMed:12884430"
FT                   /id="VAR_023826"
FT   VARIANT         440
FT                   /note="T -> S (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_046764"
FT   CONFLICT        32
FT                   /note="S -> F (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        36
FT                   /note="P -> S (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        73
FT                   /note="P -> S (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106..107
FT                   /note="PE -> SL (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        123
FT                   /note="T -> P (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127..130
FT                   /note="QKKN -> PEEE (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134..137
FT                   /note="VLDV -> CSRC (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        146..148
FT                   /note="TVN -> PVT (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        175
FT                   /note="T -> P (in Ref. 2; AAF67008)"
FT                   /evidence="ECO:0000305"
FT   HELIX           263..273
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          274..277
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           279..281
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          283..291
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          293..302
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   TURN            303..305
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          308..315
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           324..334
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          343..349
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          352..358
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           365..371
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           376..395
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           405..407
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          408..410
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   STRAND          416..418
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           441..443
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           446..449
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           458..472
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   TURN            476..479
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           482..492
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           500..502
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           505..514
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   TURN            519..521
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           525..528
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           532..536
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           540..543
FT                   /evidence="ECO:0007829|PDB:6FD3"
FT   HELIX           544..555
FT                   /evidence="ECO:0007829|PDB:6FD3"
SQ   SEQUENCE   559 AA;  62310 MW;  BC39AEC6F0A5478B CRC64;
     MSDGLDNEEK PPAPPLRMNS NNRDSSALNH SSKPLPMAPE EKNKKARLRS IFPGGGDKTN
     KKKEKERPEI SLPSDFEHTI HVGFDAVTGE FTPDLYGSQM CPGKLPEGIP EQWARLLQTS
     NITKLEQKKN PQAVLDVLKF YDSKETVNNQ KYMSFTSGDK SAHGYIAAHP SSTKTASEPP
     LAPPVSEEED EEEEEEEDEN EPPPVIAPRP EHTKSIYTRS VVESIASPAV PNKEVTPPSA
     ENANSSTLYR NTDRQRKKSK MTDEEILEKL RSIVSVGDPK KKYTRFEKIG QGASGTVYTA
     LDIATGQEVA IKQMNLQQQP KKELIINEIL VMRENKNPNI VNYLDSYLVG DELWVVMEYL
     AGGSLTDVVT ETCMDEGQIA AVCRECLQAL DFLHSNQVIH RDIKSDNILL GMDGSVKLTD
     FGFCAQITPE QSKRSTMVGT PYWMAPEVVT RKAYGPKVDI WSLGIMAIEM VEGEPPYLNE
     NPLRALYLIA TNGTPELQNP ERLSAVFRDF LNRCLEMDVD RRGSAKELLQ HPFLKLAKPL
     SSLTPLIIAA KEAIKNSSR
//
